Insulin Prices are Increasing!

Congress, AMA on alert as insulin prices soar

The Washington Post (1/7, Stanley) reports in-depth on the rising cost of insulin, “making the lifesaving medication a significant, even burdensome, expense, especially for the uninsured and underinsured.” Indeed, an IBM Watson Health analysis found the cost of insulin in the U.S. has tripled in the last ten years. The rising cost of insulin is now on the radar of Congress, and “the American Medical Association called on the government ‘to monitor insulin pricing and market competition and take enforcement actions as appropriate.’” The Post notes “Alex Azar, the head of the Department of Health and Human Services, was the president of Eli Lilly’s U.S. division until 2017,” and that Eli Lilly is among the top manufacturers of insulin. In December, meanwhile, FDA Commissioner Scott Gottlieb, M.D., issued a statement, saying, “We’ve heard frequent reports of patients rationing insulin, and in some cases dying because they can’t afford the injections they need to survive. These tragic stories aren’t isolated occurrences. And they’re not acceptable for a drug that’s nearly a century old.”

You Might Also Enjoy...

Prilosec, It's Not So Nice!

For our gut to function properly, we need stomach acid. The use of the PPI's and other antacids is detrimental to optimal health.

Crazy Doctors!

Sometimes we doctors say the darndest things to our clients (patients).